by CancerIQ, on Nov 24, 2020 3:19:08 PM
Last week, the President’s Cancer Panel titled Improving Resilience and Equity in Cancer Screening: Lessons from COVID-19 and Beyond was held over two days via conference call. This series of …
Read Storyby CancerIQ, on Nov 19, 2020 12:36:42 PM
Anchor members include Invitae, Myriad Genetics, Eurofins EGL Genetic Diagnostics, Eurofins NTD, and LabCorp CHICAGO, November 19, 2020 — CancerIQ, an enterprise precision health platform for cancer, has formed a …
Read StoryAt CancerIQ, we're dedicated to making it easier for providers to offer cancer risk assessment to every patient that walks through the door. This starts with practical implementation methods and tools (like CancerIQ)! On our blog, we'll offer best practices and advice on how to streamline your cancer risk assessment program.
515 N. State, Suite 1075
Chicago, IL 60654
Call us: 312-761-3360
info@cancer-iq.com